SZSE:301393 (China)
Â
Class A Shares
Â¥
45.45
(-1.2%)
May 24
Business Description
Suzhou Highfine Biotech Co Ltd
ISIN : CNE1000064T6
Share Class Description:
SZSE:301393: Class A SharesCompare
Compare
Traded in other countries / regions
301393.China IPO Date
2023-07-12Description
Suzhou Highfine Biotech Co Ltd is a high-tech enterprise that provides characteristic raw materials for global pharmaceutical research and development and raw material drug production companies. The products are mainly used in the fields of peptide, nucleotide and pharmaceutical synthesis. The product range covers peptide synthesis reagents for characteristic amide bond formation, molecular building blocks, protein reagents, liposome and lipid nanoparticle pharmaceutical reagents, ionic liquids , PROTAC reagents and nucleotide reagents and other types.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1289.55 | |||||
| Equity-to-Asset | 0.97 | |||||
| Debt-to-EBITDA | 0.01 | |||||
| Interest Coverage | 1349.32 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 40.88 | |||||
| Beneish M-Score | -2.97 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 6.4 | |||||
| 3-Year EBITDA Growth Rate | 25 | |||||
| 3-Year EPS without NRI Growth Rate | 26.4 | |||||
| 3-Year Book Growth Rate | 85.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 25.54 | |||||
| 9-Day RSI | 39.64 | |||||
| 14-Day RSI | 45.34 | |||||
| 6-1 Month Momentum % | -46.26 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 28.08 | |||||
| Quick Ratio | 26.52 | |||||
| Cash Ratio | 25.18 | |||||
| Days Inventory | 190.53 | |||||
| Days Sales Outstanding | 74.66 | |||||
| Days Payable | 94.49 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.55 | |||||
| Dividend Payout Ratio | 0.27 | |||||
| Forward Dividend Yield % | 0.55 | |||||
| 5-Year Yield-on-Cost % | 0.54 | |||||
| 3-Year Average Share Buyback Ratio | -10.1 | |||||
| Shareholder Yield % | 0.53 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 36.88 | |||||
| Operating Margin % | 17.87 | |||||
| Net Margin % | 26.07 | |||||
| FCF Margin % | 7.72 | |||||
| ROE % | 6.01 | |||||
| ROA % | 5.69 | |||||
| ROIC % | 12.46 | |||||
| ROC (Joel Greenblatt) % | 27.1 | |||||
| ROCE % | 6.76 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 50.5 | |||||
| PE Ratio without NRI | 49.78 | |||||
| PEG Ratio | 1.91 | |||||
| PS Ratio | 12.51 | |||||
| PB Ratio | 2.2 | |||||
| Price-to-Tangible-Book | 2.22 | |||||
| Price-to-Free-Cash-Flow | 170.86 | |||||
| Price-to-Operating-Cash-Flow | 35.98 | |||||
| EV-to-EBIT | 30.49 | |||||
| EV-to-EBITDA | 30.49 | |||||
| EV-to-Revenue | 9 | |||||
| EV-to-FCF | 125.66 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.8 | |||||
| Price-to-Graham-Number | 2.22 | |||||
| Price-to-Net-Current-Asset-Value | 2.58 | |||||
| Price-to-Net-Cash | 2.89 | |||||
| Earnings Yield (Greenblatt) % | 3.28 | |||||
| FCF Yield % | 0.56 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Suzhou Highfine Biotech Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 354.815 | ||
| EPS (TTM) (Â¥) | 0.9 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 45.34 | ||
| 14-Day ATR (Â¥) | 2.546135 | ||
| 20-Day SMA (Â¥) | 47.924 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (Â¥) | 36.51 - 118.88 | ||
| Shares Outstanding (Mil) | 108 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Suzhou Highfine Biotech Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Suzhou Highfine Biotech Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Suzhou Highfine Biotech Co Ltd Frequently Asked Questions
What is Suzhou Highfine Biotech Co Ltd(SZSE:301393)'s stock price today?
The current price of SZSE:301393 is ¥45.45. The 52 week high of SZSE:301393 is ¥118.88 and 52 week low is ¥36.51.
When is next earnings date of Suzhou Highfine Biotech Co Ltd(SZSE:301393)?
The next earnings date of Suzhou Highfine Biotech Co Ltd(SZSE:301393) is .
Does Suzhou Highfine Biotech Co Ltd(SZSE:301393) pay dividends? If so, how much?
The Dividend Yield %  of Suzhou Highfine Biotech Co Ltd(SZSE:301393) is 0.55% (As of Today), Highest Dividend Payout Ratio of Suzhou Highfine Biotech Co Ltd(SZSE:301393) was 0.27. The lowest was 0.25. And the median was 0.25. The  Forward Dividend Yield % of Suzhou Highfine Biotech Co Ltd(SZSE:301393) is 0.55%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers